XORTX Therapeutics Inc. (XRTX)
0.3791
+0.0341 (9.88%)
Inactive · Last trade price on Mar 27, 2026
XORTX Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 0.99 | 0.25 | 0.86 | 1.19 | 1.06 | 1.9 | 2.47 | 2.3 | 3.08 | 3.84 | 3.45 | 5.07 | 6.16 | 7.91 | 10.43 | 8.86 | 10.42 | 12.42 | 14.9 | 3.95 |
Cash & Short-Term Investments | 0.99 | 0.25 | 0.86 | 1.19 | 1.06 | 1.9 | 2.47 | 2.3 | 3.08 | 3.84 | 3.45 | 5.07 | 6.16 | 7.91 | 10.43 | 8.86 | 10.42 | 12.42 | 14.9 | 3.95 |
Cash Growth (YoY) | -6.53% | -86.80% | -65.05% | -48.11% | -65.45% | -50.59% | -28.25% | -54.61% | -50.06% | -51.50% | -66.96% | -42.77% | -40.84% | -36.34% | -29.95% | 124.08% | 150.73% | 158.55% | 10982.39% | 2685.04% |
Other Receivables | 0.09 | 0.06 | 0.08 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.06 | 0.07 | 0.03 | 0.04 | 0.08 | 0.06 | 0.19 | 0.12 | 0.04 | 0.02 |
Receivables | 0.09 | 0.06 | 0.08 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.06 | 0.07 | 0.03 | 0.04 | 0.08 | 0.06 | 0.19 | 0.12 | 0.04 | 0.02 |
Prepaid Expenses | 1.35 | 0.05 | 0.02 | 0.03 | 0.1 | 0.19 | 0.18 | 0.1 | 0.21 | 0.64 | 0.24 | 0.09 | 0.18 | 0.26 | 0.38 | 0.07 | 0.27 | 0.56 | 0.44 | 0.1 |
Other Current Assets | - | 0.37 | 0.29 | 0.11 | 0.09 | - | 0 | - | 0.05 | 0.16 | 0.32 | - | - | 0.01 | - | 0.45 | - | 0.18 | 0.56 | 1.94 |
Total Current Assets | 2.44 | 0.74 | 1.26 | 1.36 | 1.26 | 2.1 | 2.68 | 2.41 | 3.36 | 4.66 | 4.07 | 5.23 | 6.38 | 8.21 | 10.9 | 9.43 | 10.88 | 13.28 | 15.94 | 6 |
Property, Plant & Equipment | - | 0.01 | 0.04 | 0.06 | 0.08 | 0.02 | 0.03 | 0.05 | 0.07 | 0.02 | 0.02 | 0.04 | 0.06 | 0.08 | 0.09 | 0.1 | 0.13 | - | - | - |
Other Intangible Assets | 2.55 | 0.19 | 0.19 | 0.19 | 0.2 | 0.18 | 0.18 | 0.19 | 0.17 | 0.17 | 0.18 | 0.17 | 0.16 | 0.17 | 0.2 | 0.19 | 0.2 | 0.2 | 0.2 | 0.19 |
Other Long-Term Assets | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.19 | 1.17 | 1.25 | 1.29 | 1.27 | - |
Total Assets | 6.18 | 2.14 | 2.68 | 2.81 | 2.74 | 3.5 | 4.09 | 3.85 | 4.8 | 6.05 | 5.47 | 6.64 | 7.8 | 9.66 | 12.37 | 10.9 | 12.46 | 14.77 | 17.41 | 6.19 |
Liabilities
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Accounts Payable | 0.56 | 0.56 | 0.4 | 0.48 | 0.36 | 0.35 | 0.08 | 0.11 | 0.27 | 0.19 | 0.2 | 0.39 | 0.24 | 0.42 | 1.29 | 0.97 | 0.58 | 0.59 | 0.32 | 0.51 |
Accrued Expenses | 0.12 | 0.29 | 0.16 | 0.2 | 0.1 | 0.06 | 0.06 | 0.22 | 0.17 | 0.14 | 0.09 | 0.13 | 0.12 | 0.12 | 0.15 | 0.38 | 0.13 | 0.1 | 0.23 | 0.06 |
Current Portion of Leases | - | 0.02 | 0.04 | 0.06 | 0.08 | 0.02 | 0.04 | 0.06 | 0.08 | 0.01 | 0.01 | 0.03 | 0.05 | 0.06 | 0.07 | 0.06 | 0.07 | - | - | - |
Other Current Liabilities | 0 | 0 | 0.01 | 0.1 | 0.18 | 0.33 | 0.57 | 1.33 | 1.57 | - | 0.53 | - | - | - | - | - | - | - | - | 8.98 |
Total Current Liabilities | 0.68 | 0.86 | 0.6 | 0.84 | 0.71 | 0.76 | 0.76 | 1.72 | 2.09 | 0.34 | 0.83 | 0.55 | 0.4 | 0.6 | 1.51 | 1.42 | 0.77 | 0.69 | 0.55 | 9.55 |
Long-Term Leases | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.01 | 0.03 | 0.05 | - | - | - |
Other Long-Term Liabilities | - | - | - | - | - | - | - | - | - | 3.22 | - | - | - | - | 3.85 | 1.65 | 2.13 | 3.35 | 3.63 | - |
Total Liabilities | 0.68 | 0.86 | 0.6 | 0.84 | 0.71 | 0.76 | 0.76 | 1.72 | 2.09 | 3.56 | 0.83 | 0.55 | 0.4 | 0.6 | 5.38 | 3.1 | 2.95 | 4.04 | 4.19 | 9.55 |
Shareholders' Equity
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Common Stock | 20.8 | 20.18 | 20.18 | 19.49 | 18.91 | 18.91 | 18.49 | 17.87 | 17.87 | 17.87 | 17.06 | 17.06 | 17.06 | 17.06 | 16.52 | 14.57 | 15.53 | 16.03 | 15.81 | 10.33 |
Retained Earnings | -26.32 | -24.63 | -23.82 | -23.23 | -22.58 | -21.87 | -21.17 | -21.29 | -20.7 | -20.87 | -17.85 | -20.55 | -19.22 | -17.53 | -15.7 | -11.84 | -11.41 | -10.5 | -7.66 | -14.86 |
Comprehensive Income & Other | 11.02 | 5.73 | 5.73 | 5.72 | 5.7 | 5.7 | 6.01 | 5.55 | 5.54 | 5.49 | 5.44 | 9.58 | 9.56 | 9.53 | 6.17 | 5.07 | 5.38 | 5.21 | 5.07 | 1.18 |
Shareholders' Equity | 5.5 | 1.28 | 2.08 | 1.97 | 2.03 | 2.74 | 3.34 | 2.13 | 2.7 | 2.49 | 4.64 | 6.09 | 7.4 | 9.06 | 7 | 7.8 | 9.51 | 10.73 | 13.23 | -3.35 |
Total Liabilities & Equity | 6.18 | 2.14 | 2.68 | 2.81 | 2.74 | 3.5 | 4.09 | 3.85 | 4.8 | 6.05 | 5.47 | 6.64 | 7.8 | 9.66 | 12.37 | 10.9 | 12.46 | 14.77 | 17.41 | 6.19 |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Total Debt | - | 0.02 | 0.04 | 0.06 | 0.08 | 0.02 | 0.04 | 0.06 | 0.08 | 0.01 | 0.01 | 0.03 | 0.05 | 0.06 | 0.08 | 0.09 | 0.11 | - | - | - |
Net Cash (Debt) | 0.99 | 0.24 | 0.83 | 1.13 | 0.98 | 1.88 | 2.43 | 2.24 | 2.99 | 3.82 | 3.44 | 5.04 | 6.12 | 7.85 | 10.36 | 8.76 | 10.3 | 12.42 | 14.9 | 3.95 |
Net Cash Growth (YoY) | 1.12% | -87.49% | -66.03% | -49.32% | -67.18% | -50.81% | -29.14% | -55.58% | -51.06% | -51.30% | -66.82% | -42.49% | -40.62% | -36.83% | -30.48% | 121.75% | 147.98% | 158.55% | 10982.39% | 2685.04% |
Net Cash Per Share | 0.61 | 0.17 | 0.63 | 1.17 | 1.30 | 2.51 | 3.72 | 3.86 | 5.16 | 7.87 | 8.59 | 12.61 | 15.31 | 20.33 | 32.57 | 30.36 | 35.70 | 43.04 | 54.21 | 18.92 |
Filing Date Shares Outstanding | 1.82 | 1.39 | 1.39 | 1.39 | 1.04 | 0.76 | 0.76 | 0.64 | 0.58 | 0.58 | 0.58 | 0.4 | 0.4 | 0.4 | 0.4 | 0.32 | 0.29 | 0.29 | 0.29 | 0.29 |
Total Common Shares Outstanding | 1.73 | 1.39 | 1.39 | 1.04 | 0.76 | 0.76 | 0.7 | 0.58 | 0.58 | 0.58 | 0.4 | 0.4 | 0.4 | 0.4 | 0.33 | 0.29 | 0.29 | 0.29 | 0.29 | 0.21 |
Working Capital | 1.76 | -0.12 | 0.66 | 0.52 | 0.55 | 1.35 | 1.92 | 0.69 | 1.26 | 4.32 | 3.24 | 4.67 | 5.97 | 7.61 | 9.38 | 8.02 | 10.11 | 12.6 | 15.39 | -3.55 |
Book Value Per Share | 3.18 | 0.92 | 1.50 | 1.89 | 2.68 | 3.62 | 4.79 | 3.67 | 4.66 | 4.29 | 11.61 | 15.22 | 18.51 | 22.66 | 20.95 | 27.02 | 32.93 | 37.18 | 45.82 | -15.83 |
Tangible Book Value | 2.96 | 1.1 | 1.9 | 1.78 | 1.84 | 2.56 | 3.15 | 1.95 | 2.54 | 2.33 | 4.47 | 5.91 | 7.24 | 8.89 | 6.8 | 7.61 | 9.31 | 10.53 | 13.02 | -3.55 |
Tangible Book Value Per Share | 1.71 | 0.79 | 1.36 | 1.71 | 2.42 | 3.38 | 4.53 | 3.35 | 4.37 | 4.00 | 11.17 | 14.80 | 18.10 | 22.24 | 20.35 | 26.36 | 32.24 | 36.48 | 45.12 | -16.74 |
Machinery | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | - | - | - |